Related Experiment Video
Updated: Jun 16, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
Ana I Morales1, Dominique Detaille, Marta Prieto
1Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.
Abstract:
The antidiabetic drug metformin can diminish apoptosis induced by oxidative stress in endothelial cells and prevent vascular dysfunction even in nondiabetic patients. Here we tested whether it has a beneficial effect in a rat model of gentamicin toxicity. Mitochondrial analysis, respiration intensity, levels of reactive oxygen species, permeability transition, and cytochrome c release were assessed 3 and 6 days after gentamicin administration. Metformin treatment fully blocked gentamicin-mediated acute renal failure. This was accompanied by a lower activity of N-acetyl-beta-D-glucosaminidase, together with a decrease of lipid peroxidation and increase of antioxidant systems. Metformin also protected the kidney from histological damage 6 days after gentamicin administration. These in vivo markers of kidney dysfunction and their correction by metformin were complemented by in vitro studies of mitochondrial function. We found that gentamicin treatment depleted respiratory components (cytochrome c, NADH), probably due to the opening of mitochondrial transition pores. These injuries, partly mediated by a rise in reactive oxygen species from the electron transfer chain, were significantly decreased by metformin. Thus, our study suggests that pleiotropic effects of metformin can lessen gentamicin nephrotoxicity and improve mitochondrial homeostasis.
Insights
Metformin, an antidiabetic drug, effectively prevents acute kidney injury caused by gentamicin by protecting mitochondria and reducing oxidative stress. This study highlights metformin
Area of Science:
- Nephrology
- Pharmacology
- Mitochondrial Biology
Background:
- Gentamicin is an antibiotic known to cause nephrotoxicity.
- Oxidative stress and mitochondrial dysfunction are key mechanisms in gentamicin-induced kidney damage.
- Metformin, an antidiabetic drug, has shown protective effects against oxidative stress in endothelial cells.
Purpose of the Study:
- To investigate the protective effects of metformin against gentamicin-induced nephrotoxicity in a rat model.
- To elucidate the underlying mechanisms, particularly focusing on mitochondrial function and oxidative stress.
Main Methods:
- Rats were administered gentamicin to induce acute kidney injury.
- Metformin treatment was administered to assess its protective effects.
- Kidney function markers (N-acetyl-beta-D-glucosaminidase), oxidative stress markers (lipid peroxidation, antioxidant systems), and histological damage were assessed.
- In vitro studies evaluated mitochondrial function, including respiration, reactive oxygen species (ROS) levels, and mitochondrial permeability transition.
Main Results:
- Metformin treatment completely prevented gentamicin-mediated acute renal failure.
- Metformin reduced markers of kidney dysfunction, such as N-acetyl-beta-D-glucosaminidase activity, lipid peroxidation, and increased antioxidant systems.
- Histological examination showed metformin protected the kidney from damage.
- In vitro studies confirmed that metformin decreased gentamicin-induced mitochondrial dysfunction, including the depletion of respiratory components and opening of mitochondrial transition pores, partly by reducing ROS generation.
Conclusions:
- Metformin exhibits significant renoprotective effects against gentamicin-induced nephrotoxicity.
- These protective effects are mediated through the improvement of mitochondrial homeostasis and reduction of oxidative stress.
- Metformin's pleiotropic actions offer a potential therapeutic strategy to mitigate antibiotic-induced kidney injury.
Related Concept Videos
Diabetic Nephropathy
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Oral Hypoglycemic Agents: Biguanides and Glitazones
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

